Experience

Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $3 billion aggregate principal amount of 3.125% fixed-rate senior notes due 2026. The lead manager…

Davis Polk advised the sole underwriter in connection with the approximately $260 million secondary offering of 12,500,000 shares of common stock of Summit Materials, Inc. by certain…

Davis Polk advised Cosan Luxembourg S.A., as issuer, and Cosan S.A. Indústria e Comércio, as guarantor, in connection with the issuance by Cosan Luxembourg of $150 million 7.000% senior…

Davis Polk advised Sumitomo Mitsui Financial Group, Inc. (SMFG) on its SEC-registered takedown offering, which consisted of $1.75 billion aggregate principal amount of 2.058% senior notes…

Davis Polk advised Yihai International Holding Ltd. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on…

Davis Polk advised Orient Securities Company Limited (“DFZQ”) on its initial public offering and listing on the Main Board of The Stock Exchange of Hong Kong Limited and an international…

Davis Polk advised the joint global coordinators on the initial public offering and listing on the Main Board of The Stock Exchange of Hong Kong Limited and an international offering in…

Davis Polk advised GE Capital Global Holdings, LLC (GE Capital) on its successful request for rescission of its designation as a nonbank systemically important financial institution (SIFI)…

Davis Polk advised the administrative agent in connection with a $200 million term loan facility (the “Credit Facility”) for Magellan Pharmacy Services, Inc., a wholly owned subsidiary of…

Davis Polk advised the joint book-running managers in connection with the $120 million follow-on offering of common stock of Global Blood Therapeutics, Inc. Global Blood’s common stock is…